Equity and Quality of Global Chronic Kidney Disease Care: What Are We Waiting for?
American Journal of Nephrology · 2024 · 55 (3) · 298-315
DOI: 10.1159/000535864 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Nephrology, online erschienen am 18.12.2023. Verfasst von Valerie A Luyckx und 8 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics and Prevention Institute, Department of Public and Global Health, Epidemiology, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Global Health, Quality of Health Care. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMHD NIH HHS, NIDDK NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background: Chronic kidney disease (CKD) is an important but insufficiently recognized public health problem. Unprecedented advances in delaying progression of CKD and reducing kidney failure and death have been made in recent years, with the addition of the sodium-glucose cotransporter 2 inhibitors and other newer medication to the established standard of care with inhibitors of the renin-angiotensin system. Despite knowledge of these effective therapies, their prescription and use remain suboptimal globally, and more specially in low resource settings. Many challenges contribute to this gap between knowledge and translation into clinical care, which is even wider in lower resource settings across the globe. Implementation of guideline-directed care is hampered by lack of disease awareness, late or missed diagnosis, clinical inertia, poor quality care, cost of therapy, systemic biases, and lack of patient empowerment. All of these are exacerbated by the social determinants of health and global inequities. Summary: CKD is a highly manageable condition but requires equitable and sustainable access to quality care supported by health policies, health financing, patient and health care worker education, and affordability of medications and diagnostics. Key Messages: The gap between the knowledge and tools to treat CKD and the implementation of optimal quality kidney care should no longer be tolerated. Advocacy, research and action are required to improve equitable access to sustainable quality care for CKD everywhere.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biostatistics and Prevention Institute, Department of Public and Global Health, Epidemiology, University of Zurich, Zurich, Switzerland.
- Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.
- Division of Pediatric Nephrology, University of Virginia Children's Hospital, Charlottesville, Virginia, USA.
- Department of Nephrology, Osmania Medical College and General Hospital, KNR Universtiy, Warangal, India.
- Rural and Remote Health, Flinders University, Alice Springs, Northern Territory, Australia.
Förderung
- NIMHD NIH HHS
- NIDDK NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Luyckx, V. A., Elmaghrabi, A., Sahay, M., Scholes-Robertson, N., Sola, L., Speare, T., Tannor, E. K., Tuttle, K. R., & Okpechi, I. G. (2024). Equity and Quality of Global Chronic Kidney Disease Care: What Are We Waiting for?. American Journal of Nephrology, 55(3), 298-315. https://doi.org/10.1159/000535864
Vancouver
Luyckx VA, Elmaghrabi A, Sahay M, Scholes-Robertson N, Sola L, Speare T, et al. Equity and Quality of Global Chronic Kidney Disease Care: What Are We Waiting for?. American Journal of Nephrology. 2024;55(3):298-315. doi:10.1159/000535864
BibTeX
@article{Luyckx2024,
author = {Luyckx, Valerie A and Elmaghrabi, Ayah and Sahay, Manisha and Scholes-Robertson, Nicole and Sola, Laura and Speare, Tobias and Tannor, Elliot K and Tuttle, Katherine R and Okpechi, Ikechi G},
title = {Equity and Quality of Global Chronic Kidney Disease Care: What Are We Waiting for?},
journal = {American Journal of Nephrology},
year = {2024},
volume = {55},
number = {3},
pages = {298--315},
doi = {10.1159/000535864}
}
EUVIMED